CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020		Dec. 31, 2019
Cash Flows from Operating Activities
Net loss		$ (193.5)	$ (365.5)		$ (1.3)
Loss from discontinued operations, net of tax		(18.5)	(27.9)		(36.6)
(Loss) income from continuing operations		(175.0)	(337.6)		35.3
Adjustments to reconcile net (loss) income from continuing operations to net cash (used) provided by operating activities:
Depreciation		50.4	57.3		68.1
Amortization		22.4	24.5		24.8
Provision for doubtful accounts		62.4	78.3		115.4
Provision for inventory obsolescence		26.8	37.9		37.1
Share-based compensation		6.9	26.4		15.6
Foreign exchange (gains) losses		(5.2)	(5.1)		(51.5)
Deferred income taxes		(20.2)	(0.4)		37.5
Impairment loss on assets		1.0	3.1		17.7
Gain on sale of business / assets		(9.9)	(1.5)		(50.1)
Certain Brazil indirect taxes		0.0	0.0		(118.3)
Other		5.9	54.2		12.0
Changes in assets and liabilities:
Accounts receivable		(60.1)	(81.5)		(55.2)
Inventories		(53.0)	(65.9)		56.0
Prepaid expenses and other		(14.9)	1.2		25.7
Accounts payable and accrued liabilities		(35.1)	(61.7)		(145.4)
Income and other taxes		(13.1)	2.5		28.8
Noncurrent assets and liabilities		(49.7)	(1.8)		3.4
Net cash (used) provided by operating activities of continuing operations		(260.4)	(270.1)		56.9
Cash Flows from Investing Activities
Capital expenditures		(68.3)	(44.6)		(58.5)
Disposal of assets		3.3	2.6		7.8
Net proceeds from sale of business / assets		16.9	11.3		99.9
Cash receipts from the settlement of corporate-owned life insurance policies		0.0	9.9		0.0
Other investing activities		0.0	0.3		1.0
Net cash (used) provided by investing activities of continuing operations		(48.1)	(20.5)		50.2
Cash Flows from Financing Activities
Cash dividend		0.0	(8.6)		0.0
Debt, net (maturities of three months or less)		(11.1)	13.6		(9.2)
Proceeds from debt		297.0	1,039.7		400.0
Repayment of debt		(68.5)	(956.9)		(388.2)
Repayment of debt to affiliates of Natura &Co	[1]	(38.0)	0.0		0.0
Repayment of debt from affiliates of Natura &Co		58.7	0.0		0.0
Repurchase of common stock		0.0	(0.4)		(9.6)
Net proceeds from exercise of stock options		0.0	0.0		15.6
Settlement of stock options		0.0	(25.8)		0.0
Settlement of derivative operations		0.0	(0.8)		37.4
Costs associated with debt issue / repayment		0.0	(21.7)		(26.8)
Proceeds from monetization of COFINS tax credits		(15.5)	0.0		19.4
Other financing activities		0.0	0.0		(0.1)
Net cash provided by financing activities of continuing operations(2)	[1]	222.6	39.1		38.5
Cash Flows from Discontinued Operations
Net cash used by operating activities of discontinued operations		(14.0)	(16.7)		(20.6)
Net cash used by discontinued operations		(14.0)	(16.7)		(20.6)
Effect of exchange rate changes on cash and cash equivalents		(22.0)	(19.5)		(0.3)
Net (decrease) increase in cash and cash equivalents and restricted cash		(121.9)	(287.7)		124.7
Cash and cash equivalents and restricted cash at beginning of year	[2]	373.4	661.1		536.4
Cash and cash equivalents and restricted cash at end of year		251.5	373.4	[2]	661.1	[2]
Cash paid for:
Interest		50.1	133.5		122.0
Income taxes, net of refunds received		$ 37.0	$ 21.3		$ 55.9

[1] On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding for $150, with the proceeds used to repay maturing loans of $150 borrowed under the $250 Revolving Credit Facility with a subsidiary of Natura &Co Holding. Under the terms of the transaction and the associated Direction and Settlement Agreement, no cash flows in either investing or financing activities arose as a result of the transaction.

[2] The following table provides a reconciliation of cash, cash equivalents, restricted cash, and cash held for sale reported within the Consolidated Balance Sheet that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows for the years ended December 31, 2021, 2020 and 2019. December 31, 2021December 31, 2020December 31, 2019Cash and cash equivalents$251.5 $364.9 $650.6 Restricted cash— 7.8 2.9 Long-term restricted cash— — 7.6 Held for sale cash and cash equivalents— .7 — Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows$251.5 $373.4 $661.1